Literature DB >> 7770934

A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture.

T D Sielaff1, M Y Hu, S Rao, K Groehler, D Olson, H J Mann, R P Remmel, R A Shatford, B Amiot, W S Hu.   

Abstract

Current bioartificial liver devices are based on the use of a large mass of hepatocytes exhibiting differentiated metabolic function. The pig has become a source of interest for the acquisition of such cells-however, harvesting a large mass of highly viable cells has met with difficulty. This study describes a technique for harvesting large quantities of hepatocytes at viabilities greater than 90% and also describes several features documenting differentiated function. Pigs, 6 to 10 kg body weight, underwent in situ two-step whole liver perfusion (ethylene glycol tetraacetic acid and collagenase) and ex vivo cell harvest. Harvests yielded an average of 19.5 billion cells with an average viability of 94.6%. Hepatocytes were then entrapped in type I collagen (3 x 10(5) cells/well) and cultured in serum-free media for 5 days. Pig hepatocytes produced stable amounts of albumin and maintained cytochrome P-450 and glucuronidation activity over 5 days, as shown by the metabolism of lidocaine and 4-methylumbelliferone. These data indicate that pig hepatocytes can be harvested with high yields and can retain viability and differentiated function over at least 5 days of culture, and therefore should prove to be an excellent source of hepatocytes for bioartificial liver devices.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770934     DOI: 10.1097/00007890-199505270-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions.

Authors:  K Nakazawa; H Mizumoto; M Kaneko; H Ijima; T Gion; M Shimada; K Shirabe; K Takenaka; K Sugimachi; K Funatsu
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

2.  Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models.

Authors:  Clara T Nicolas; Raymond D Hickey; Kari L Allen; Zeji Du; Rebekah M Guthman; Robert A Kaiser; Bruce Amiot; Aditya Bansal; Mukesh K Pandey; Lukkana Suksanpaisan; Timothy R DeGrado; Scott L Nyberg; Joseph B Lillegard
Journal:  Surgery       Date:  2018-06-06       Impact factor: 3.982

3.  Pivotal preclinical trial of the spheroid reservoir bioartificial liver.

Authors:  Jaime M Glorioso; Shennen A Mao; Brian Rodysill; Taufic Mounajjed; Walter K Kremers; Faysal Elgilani; Raymond D Hickey; Hakon Haugaa; Christopher F Rose; Bruce Amiot; Scott L Nyberg
Journal:  J Hepatol       Date:  2015-03-25       Impact factor: 25.083

4.  Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Posthepatectomy Liver Failure.

Authors:  Harvey S Chen; Dong Jin Joo; Mohammed Shaheen; Yi Li; Yujia Wang; Jian Yang; Clara T Nicolas; Kelly Predmore; Bruce Amiot; Gregory Michalak; Taofic Mounajjed; Jeff Fidler; Walter K Kremers; Scott L Nyberg
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

Review 5.  Extracorporeal bioartificial liver for treating acute liver diseases.

Authors:  Ashok Kumar; Anuj Tripathi; Shivali Jain
Journal:  J Extra Corpor Technol       Date:  2011-12

6.  Development of a bioartificial liver employing xenogeneic hepatocytes.

Authors:  W S Hu; J R Friend; F J Wu; T Sielaff; M V Peshwa; A Lazar; S L Nyberg; R P Remmel; F B Cerra
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

7.  Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.

Authors:  Raymond D Hickey; Shennen A Mao; Jaime Glorioso; Faysal Elgilani; Bruce Amiot; Harvey Chen; Piero Rinaldo; Ronald Marler; Huailei Jiang; Timothy R DeGrado; Lukkana Suksanpaisan; Michael K O'Connor; Brittany L Freeman; Samar H Ibrahim; Kah Whye Peng; Cary O Harding; Chak-Sum Ho; Markus Grompe; Yasuhiro Ikeda; Joseph B Lillegard; Stephen J Russell; Scott L Nyberg
Journal:  Sci Transl Med       Date:  2016-07-27       Impact factor: 17.956

8.  Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems : State of the art and future developments of hepatic cell culture techniques for the use in liver support systems.

Authors:  Sonja Diekmann; Augustinus Bader; Stephanie Schmitmeier
Journal:  Cytotechnology       Date:  2006-06-23       Impact factor: 2.058

9.  An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.

Authors:  Claire A Schreiber; Toshie Sakuma; Yoshihiro Izumiya; Sara J Holditch; Raymond D Hickey; Robert K Bressin; Upamanyu Basu; Kazunori Koide; Aravind Asokan; Yasuhiro Ikeda
Journal:  PLoS Pathog       Date:  2015-08-05       Impact factor: 6.823

10.  Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro.

Authors:  Leonard J Nelson; Philipp Treskes; A Forbes Howie; Simon W Walker; Peter C Hayes; John N Plevris
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.